These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 26944006)
41. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai. Shah I; Shah F Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119 [TBL] [Abstract][Full Text] [Related]
42. Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous antituberculosis treatment: A systematic review and meta-analysis. Eshetie S; Moges F; Dagnew M Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S119-S120. PubMed ID: 28043498 [TBL] [Abstract][Full Text] [Related]
43. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience. Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of multidrug and extensively drug-resistant tuberculosis in Beijing, China: a hospital-based retrospective study. Wang D; Yang C; Kuang T; Lei H; Meng X; Tong A; He J; Jiang Y; Guo F; Dong M Jpn J Infect Dis; 2010 Sep; 63(5):368-71. PubMed ID: 20859008 [TBL] [Abstract][Full Text] [Related]
45. Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis. Jimma W; Ghazisaeedi M; Shahmoradi L; Abdurahman AA; Kalhori SRN; Nasehi M; Yazdi S; Safdari R Rev Soc Bras Med Trop; 2017; 50(3):287-295. PubMed ID: 28700044 [TBL] [Abstract][Full Text] [Related]
46. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview. Silva C; Perdigão J; Jordão L; Portugal I Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633 [TBL] [Abstract][Full Text] [Related]
47. Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes. Ayaz A; Hasan Z; Jafri S; Inayat R; Mangi R; Channa AA; Malik FR; Ali A; Rafiq Y; Hasan R Int J Infect Dis; 2012 Apr; 16(4):e303-9. PubMed ID: 22365136 [TBL] [Abstract][Full Text] [Related]
48. Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review. Pang Y; Lu J; Huo F; Ma Y; Zhao L; Li Y; Liang Q; Chu N; Gao M; Huang H J Infect; 2017 Nov; 75(5):433-440. PubMed ID: 28804028 [TBL] [Abstract][Full Text] [Related]
49. Social behaviour risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. Zhao P; Li XJ; Zhang SF; Wang XS; Liu CY J Int Med Res; 2012; 40(2):436-45. PubMed ID: 22613404 [TBL] [Abstract][Full Text] [Related]
50. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions. Prasad R Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336 [TBL] [Abstract][Full Text] [Related]
51. Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data. Zignol M; Dara M; Dean AS; Falzon D; Dadu A; Kremer K; Hoffmann H; Hoffner S; Floyd K Drug Resist Updat; 2013 Dec; 16(6):108-15. PubMed ID: 24631052 [TBL] [Abstract][Full Text] [Related]
52. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis. Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562 [TBL] [Abstract][Full Text] [Related]
53. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894 [TBL] [Abstract][Full Text] [Related]
54. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China. Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979 [TBL] [Abstract][Full Text] [Related]
56. Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014. Chuang PH; Wu MH; Fan SY; Lin KY; Jou R PLoS One; 2016; 11(11):e0165222. PubMed ID: 27846235 [TBL] [Abstract][Full Text] [Related]
57. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997]. Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966 [TBL] [Abstract][Full Text] [Related]
58. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions. Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027 [TBL] [Abstract][Full Text] [Related]
59. Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India. Prakash R; Kumar D; Gupta VK; Jain S; Chauhan DS; Tiwari PK; Katoch VM J Infect Public Health; 2016; 9(3):289-97. PubMed ID: 26775848 [TBL] [Abstract][Full Text] [Related]
60. Drug resistance pattern of mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007. Yu CC; Chang CY; Liu CE; Shih LF; Hsiao JH; Chen CH J Microbiol Immunol Infect; 2010 Aug; 43(4):285-90. PubMed ID: 20688288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]